Posted on July 16, 2019 by Sitemaster
According to the newest and largest known analysis of data currently available, there is a small but statistically significant association between treatment with androgen deprivation therapy (ADT) and increase in risk for Alzheimer’s disease and/or dementia over time. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, Alzheimer, androgen, association, dementia, deprivation | 10 Comments »
Posted on November 8, 2018 by Sitemaster
We have long been bedeviled by questions about some of the short- and the long-term side effects and complications of androgen deprivation therapy (ADT) in the treatment of prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, Alzheimer's, androgen, dementia, deprivation, failure, heart, side effect | 2 Comments »
Posted on January 24, 2018 by Sitemaster
As regular readers will be aware, there has been some intense debate over the past year or so about whether there is an association between treatment with androgen deprivation therapy (ADT) and risk for dementia. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, androgen, cognitive, dementia, deprivation, dysfunction, function | 7 Comments »
Posted on September 7, 2017 by Sitemaster
A new study has concluded that added risk for Alzheimer’s disease and dementia among Medicare patients with prostate cancer who were treated with androgen deprivation therapy (ADT) was minimal in men treated between 2001 and 2014. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, Alzheimer's, androgen, dementia, deprivation | 1 Comment »
Posted on November 29, 2016 by Sitemaster
Just a few weeks ago we reported data from a study in California suggesting an association between treatment with androgen deprivation therapy (ADT) for prostate cancer and subsequent risk for diagnosis with dementia or Alzheimer’s disease. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, dementia, deprivation, risk, therapy | Leave a comment »
Posted on October 14, 2016 by Sitemaster
Back in December last year, a group of researchers suggested that androgen deprivation therapy (ADT) might be associated with increased risk for Alzheimer’s disease (see “Is ADT giving you Alheimer’s disease?“) … READ MORE …
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ADT, Alzheimer's, androgen, dementia, deprivation, risk | 11 Comments »